Just the 20th company to go public amid this year's bear market, Acrivon Therapeutics announced the pricing of its IPO Tuesday, putting all of its 7,550,000 shares of common stock up for sale for $12.50 apiece.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,